arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2201.07463eess.IVcs.LG

Cortical lesions, central vein sign, and paramagnetic rim lesions in multiple sclerosis: emerging machine learning techniques and future avenues

Ecole Polytechnique Fédérale de Lausanne (EPFL)(洛桑联邦理工学院);CIBM Center for Biomedical Imaging(CIBM生物医学影像中心);UCLouvain(鲁汶大学);Lausanne University and University Hospital(洛桑大学及大学医院);National Institute of Neurological Disorders and Stroke, National Institutes of Health(美国国立卫生研究院国家神经疾病与卒中研究所);Cedars-Sinai Medical Center(西达赛奈医疗中心);Icahn School of Medicine at Mount Sinai(西奈山伊坎医学院);Siemens Healthcare AG(西门子医疗股份公司);Cliniques universitaires Saint-Luc, Université catholique de Louvain(圣吕克大学医院,天主教鲁汶大学);CHUV(洛桑大学医院);University of Pennsylvania(宾夕法尼亚大学);Perelman School of Medicine, University of Pennsylvania(宾夕法尼亚大学佩雷尔曼医学院);University Hospital Basel and University of Basel(巴塞尔大学医院及巴塞尔大学);IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University(圣拉斐尔医院及圣拉斐尔生命健康大学);Johns Hopkins University School of Medicine(约翰斯·霍普金斯大学医学院)
Francesco La Rosa, Maxence Wynen, Omar Al-Louzi, Erin S Beck, Till Huelnhagen, Pietro Maggi, Jean-Philippe Thiran, Tobias Kober, Russell T Shinohara, Pascal Sat… 展开作者

Francesco La Rosa, Maxence Wynen, Omar Al-Louzi, Erin S Beck, Till Huelnhagen, Pietro Maggi, Jean-Philippe Thiran, Tobias Kober, Russell T Shinohara, Pascal Sati, Daniel S Reich, Cristina Granziera, Martina Absinta, Meritxell Bach Cuadra

英文摘要:

The current multiple sclerosis (MS) diagnostic criteria lack specificity, and this may lead to misdiagnosis, which remains an issue in present-day clinical practice. In addition, conventional biomarkers only moderately correlate with MS disease progression. Recently, advanced MS lesional imaging biomarkers such as cortical lesions (CL), the central vein sign (CVS), and paramagnetic rim lesions (PRL), visible in specialized magnetic resonance imaging (MRI) sequences, have shown higher specificity in differential diagnosis. Moreover, studies have shown that CL and PRL are potential prognostic biomarkers, the former correlating with cognitive impairments and the latter with early disability progression. As machine learning-based methods have achieved extraordinary performance in the assessment of conventional imaging biomarkers, such as white matter lesion segmentation, several automated or semi-automated methods have been proposed for CL, CVS, and PRL as well. In the present review, we first introduce these advanced MS imaging biomarkers and their imaging methods. Subsequently, we describe the corresponding machine learning-based methods that were used to tackle these clinical questions, putting them into context with respect to the challenges they are still facing, including non-standardized MRI protocols, limited datasets, and moderate inter-rater variability. We conclude by presenting the current limitations that prevent their broader deployment and suggesting future research directions.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑